Clinical Trials Browser

Hearing Loss × 1 year × Clear all

NCT04915183 2026-03-09

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Phase 2 Recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hearing Loss

NCT06517888 2026-03-04

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Phase 1/2 Recruiting

Neuroma, Acoustic, Hearing Loss

NCT07420751 2026-02-20

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Phase NA Recruiting

Neurofibromatosis 2, Hearing Loss

NCT07407582 2026-02-12

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

Phase 1/2 Not yet recruiting

GenitourinaryHead & Neck

Head and Neck Neoplasms, Neoplasms, Testicular Neoplasms, Hearing Loss

NCT07218913 2026-01-26

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

Phase 1 Recruiting

Testicular Neoplasms, Seminoma, Hearing Loss

NCT06781749 2026-01-13

New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss

Dementia, Hearing Loss

NCT05789316 2026-01-12

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Phase NA Completed

Ototoxicity, Head and Neck Neoplasms, Hearing Loss

NCT05582551 2025-12-22

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Phase NA Recruiting

Neoplasms, Peripheral Nervous System Diseases, Hearing Loss

NCT02425397 2025-12-01

OTOPLAT

Ototoxicity, Neoplasms, Hearing Loss

NCT06303180 2025-11-14

NIDCD Otolaryngology Clinical Protocol Biospecimen Bank

Head and Neck Neoplasms, Hearing Disorders, Laryngeal Diseases, Speech, Hearing Loss

NCT02310399 2025-10-30

Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves

Phase NA Recruiting

Deafness, Hearing Loss

NCT06036407 2025-05-30

HEAR

Phase NA Completed

Ototoxicity, Neoplasms, Hearing Loss

NCT06894927 2025-05-30

HSA50+

Phase NA Enrolling by invitation

Presbycusis, Hearing Loss

NCT06551857 2025-04-16

CaSPiN

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

NCT06929468 2025-04-16

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Ototoxicity, Deafness, Dizziness, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Vestibular Diseases, Hearing Loss